We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
160 result(s) found, displaying 21 to 30
-
Cancellation or suspensionCancelled from the ARTG under subsection 30(2)(a) of the Act. It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS IBUPROFEN TABLETS ibuprofen 200 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: ticagrelor.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FEXACLEAR fexofenadine hydrochloride 120 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FEXACLEAR fexofenadine hydrochloride 180 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRUST RESTAMINE doxylamine succinate 25 mg tablet blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN LUPIN XR metformin hydrochloride 500 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN SANDOZ XR metformin hydrochloride 1000 mg extended release tablet blister pack.